pH-Responsive Biodegradable Assemblies Containing Tunable Phenyl-Substituted Vinyl Ethers for Use as Efficient Gene Delivery Vehicles
- 17 June 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 5 (12) , 5648-5658
Abstract
Novel pH-responsive assemblies (PEG-lipid:DOPE liposomes) containing tunable and bifunctional phenyl-substituted vinyl ether (PIVE) cross-linkers were prepared. The assemblies consisted of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), acid-cleavable poly(ethylene glycol) (PEG)-conjugated lipids, pDNA, and protamine sulfate (PS). The PIVE linkage was designed to hydrolyze under acidic conditions, and the hydrolysis studies of PEG-lipid compounds containing PIVE at pH 4.2, 5.4, and 7.4 indicated that the hydrolysis rates of PIVE linker were influenced by the substitution of electron withdrawing or electron donating groups on the phenyl ring. Acid-catalyzed hydrolysis of PIVE leads to destabilization of the acid labile PEG-PIVE-lipid:DOPE liposomes via dePEGylation, thereby triggering content release. Content release assays showed that dePEGylation was highly pH-dependent and correlated with the PIVE proton affinity of the phenyl group. These results indicated that the dePEGylative triggering based on a new pH-sensitive PIVE linkage can be controlled. In vitro transfection studies on the pH-responsive assemblies containing mPEG-(MeO-PIVE)-conjugated 1,3-dioctadecyl-rac-glycerol lipids (mPEG-(MeO-PIVE])-DOG) showed higher transfection efficiency compared to that of polyethylenimine (PEI), a positive control, on HEK 293 and COS-7 cells. In addition, lower cytotoxicity of PEG-PIVE-lipid:DOPE liposomes/PS/DNA was observed in comparison to PEI. These results suggest that PEG-PIVE-lipid:DOPE liposomes can be considered as nonviral vehicles for drug and gene delivery applications.Keywords
This publication has 65 references indexed in Scilit:
- CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based TherapeuticsJournal of Pharmaceutical Sciences, 2011
- Biomedical applications of dendrimers: a tutorialChemical Society Reviews, 2010
- Rational design of cationic lipids for siRNA deliveryNature Biotechnology, 2010
- Gene therapy for red–green colour blindness in adult primatesNature, 2009
- Engineering targeted viral vectors for gene therapyNature Reviews Genetics, 2007
- Design and development of polymers for gene deliveryNature Reviews Drug Discovery, 2005
- Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cellsAdvanced Drug Delivery Reviews, 2005
- Barriers to Nonviral Gene DeliveryJournal of Pharmaceutical Sciences, 2003
- Tumor pH: Implications for treatment and novel drug designSeminars in Radiation Oncology, 1998
- ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYSAnnual Review of Biochemistry, 1986